CeriBell, Inc. Operating Cash Flow
CeriBell, Inc. (CBLL) reported Operating Cash Flow of -$32.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- CeriBell, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$12.86M.
- CeriBell, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$19.30M.
- CeriBell, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$10.77M.
- CeriBell, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$11.10M.
- CeriBell, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$40.81M.
- CeriBell, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$35.04M.
- CeriBell, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$29.16M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$32.16M 10-Q · filed 2026-08-10 | -$42.93M derived: sum of 3 quarters · filed 2026-08-10 | -$54.03M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$19.30M 10-Q · filed 2026-05-11 | -$30.07M derived: sum of 2 quarters · filed 2026-05-11 | -$41.17M derived: sum of 3 quarters · filed 2026-05-11 | -$48.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$21.87M derived: sum of 2 quarters · filed 2026-02-24 | -$29.41M derived: sum of 3 quarters · filed 2026-08-10 | -$40.81M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$18.63M derived: sum of 2 quarters · filed 2026-08-10 | -$30.03M 10-Q · filed 2025-11-04 | -$40.01M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$7.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$18.94M 10-Q · filed 2026-08-10 | -$28.91M derived: sum of 3 quarters · filed 2026-08-10 | -$37.45M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$11.40M 10-Q · filed 2026-05-11 | -$21.38M derived: sum of 2 quarters · filed 2026-05-11 | -$29.92M derived: sum of 3 quarters · filed 2026-05-11 | -$36.90M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$18.52M derived: sum of 2 quarters · filed 2026-02-24 | -$25.49M derived: sum of 3 quarters · filed 2026-02-24 | -$35.04M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$8.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$15.52M derived: sum of 2 quarters · filed 2025-11-04 | -$25.07M 10-Q · filed 2025-11-04 | -$31.74M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$6.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$16.53M 10-Q · filed 2025-08-05 | -$23.20M derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | -$9.55M 10-Q · filed 2025-05-08 | -$16.23M derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$29.16M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | -$22.48M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |